1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    
























































































































    Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleHead & Neck

  
      

  
      
Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging
  
    	
Y. Ota, E. Liao, A.A. Capizzano, A. Baba, R. Kurokawa, M. Kurokawa and A. Srinivasan

  
    	
American Journal of Neuroradiology September 2022,  43 (9) 1325-1332; DOI: https://doi.org/10.3174/ajnr.A7607 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵
    1. Kelly  HR, 
    2. Curtin  HD
    . Imaging of skull base lesions. Handb Clin Neurol 2016;135:637–57 doi:10.1016/B978-0-444-53485-9.00030-1 pmid:27432686
    CrossRefPubMed
  2. 2.↵
    1. Dolecek  TA, 
    2. Propp  JM, 
    3. Stroup  NE, et al
    . CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 2012;1(Suppl 5):v1–49 doi:10.1093/neuonc/nos218 pmid:23095881
    CrossRefPubMed
  3. 3.↵
    1. Almefty  K, 
    2. Pravdenkova  S, 
    3. Colli  BO, et al
    . Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer 2007;110:2467–67 doi:10.1002/cncr.23073 pmid:17894390
    CrossRefPubMed
  4. 4.↵
    1. Pamir  MN, 
    2. Ozduman  K
    . Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas. Eur J Radiol 2006;58:461–70 doi:10.1016/j.ejrad.2006.03.020 pmid:16631334
    CrossRefPubMed
  5. 5.↵
    1. Mehta  GU, 
    2. Raza  SM
    . Management of skull base metastases. Neurosurg Clin N Am 2020;31:659–66 doi:10.1016/j.nec.2020.06.013 pmid:32921360
    CrossRefPubMed
  6. 6.↵
    1. Chaichana  KL, 
    2. Flores  M, 
    3. Acharya  S, et al
    . Survival and recurrence for patients undergoing surgery of skull base intracranial metastases. J Neurol Surg B Skull Base 2013;74:228–35 doi:10.1055/s-0033-1342925 pmid:24436917
    CrossRefPubMed
  7. 7.↵
    1. Laigle-Donadey  F, 
    2. Taillibert  S, 
    3. Martin-Duverneuil  N, et al
    . Skull-base metastases. J Neurooncol 2005;75:63–69 doi:10.1007/s11060-004-8099-0 pmid:16215817
    CrossRefPubMed
  8. 8.↵
    1. Mitsuya  K, 
    2. Nakasu  Y, 
    3. Horiguchi  S, et al
    . Metastatic skull tumors: MRI features and a new conventional classification. J Neurooncol 2011;104:239–45 doi:10.1007/s11060-010-0465-5 pmid:21110218
    CrossRefPubMed
  9. 9.↵
    1. Kremenevski  N, 
    2. Schlaffer  SM, 
    3. Coras  R, et al
    . Skull base chordomas and chondrosarcomas. Neuroendocrinology 2020;110:836–47 doi:10.1159/000509386 pmid:32541136
    CrossRefPubMed
  10. 10.↵
    1. Surov  A, 
    2. Meyer  HJ, 
    3. Wienke  A
    . Apparent diffusion coefficient for distinguishing between malignant and benign lesions in the head and neck region: a systematic review and meta-analysis. Front Oncol 2019;9:1362 doi:10.3389/fonc.2019.01362 pmid:31970081
    CrossRefPubMed
  11. 11.↵
    1. Gaddikeri  S, 
    2. Gaddikeri  RS, 
    3. Tailor  T, et al
    . Dynamic contrast-enhanced MR imaging in head and neck cancer: techniques and clinical applications. AJNR Am J Neuroradiol 2016;37:588–95 doi:10.3174/ajnr.A4458 pmid:26427839
    Abstract/FREE Full Text
  12. 12.
    1. Ota  Y, 
    2. Moore  AG, 
    3. Spector  ME, et al
    . Prediction of wound failure in patients with head and neck cancer treated with free flap reconstruction: utility of CT perfusion and MR perfusion in the early postoperative period. AJNR Am J Neuroradiol 2022;43:585–91 doi:10.3174/ajnr.A7458] pmid:35361578
    Abstract/FREE Full Text
  13. 13.
    1. Ota  Y, 
    2. Liao  E, 
    3. Capizzano  AA, et al
    . MR diffusion and dynamic-contrast enhanced imaging to distinguish meningioma, paraganglioma, and schwannoma in the cerebellopontine angle and jugular foramen. J Neuroimaging 2021;32:502–10 doi:10.1111/jon.12959 pmid:34936708
    CrossRefPubMed
  14. 14.↵
    1. Ota  Y, 
    2. Naganawa  S, 
    3. Kurokawa  R, et al
    . Assessment of MR imaging and CT in differentiating hereditary and nonhereditary paragangliomas. AJNR Am J Neuroradiol 2021;42:1320–26 doi:10.3174/ajnr.A7166 pmid:33985956
    Abstract/FREE Full Text
  15. 15.↵
    1. Ota  Y, 
    2. Liao  E, 
    3. Capizzano  AA, et al
    . Diagnostic role of diffusion-weighted and dynamic contrast-enhanced perfusion MR imaging in paragangliomas and schwannomas in the head and neck. AJNR Am J Neuroradiol 2021;42:1839–46 doi:10.3174/ajnr.A7266 pmid:34446460
    Abstract/FREE Full Text
  16. 16.↵
    1. Ota  Y, 
    2. Liao  E, 
    3. Kurokawa  R, et al
    . Diffusion-weighted and dynamic contrast-enhanced MRI to assess radiation therapy response for head and neck paragangliomas. J Neuroimaging 2021;31:1035–43 doi:10.1111/jon.12875 pmid:34002429
    CrossRefPubMed
  17. 17.↵
    1. Yeom  KW, 
    2. Lober  RM, 
    3. Mobley  BC, et al
    . Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma. AJNR Am J Neuroradiol 2013;34:1056–61, S1 doi:10.3174/ajnr.A3333 pmid:23124635
    Abstract/FREE Full Text
  18. 18.↵
    1. Guan  Y, 
    2. Peck  KK, 
    3. Lyo  J, et al
    . T1-weighted dynamic contrast-enhanced MRI to differentiate nonneoplastic and malignant vertebral body lesions in the spine. Radiology 2020;297:382–89 doi:10.1148/radiol.2020190553 pmid:32870135
    CrossRefPubMed
  19. 19.↵
    1. Ginat  DT, 
    2. Mangla  R, 
    3. Yeaney  G, et al
    . Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density. AJR Am J Roentgenol 2012;198:W597–601 doi:10.2214/AJR.11.7424 pmid:22623576
    CrossRefPubMed
  20. 20.↵
    1. Koontz  NA, 
    2. Wiggins  RH   3rd.
     Differentiation of benign and malignant head and neck lesions with diffusion tensor imaging and DWI. AJR Am J Roentgenol 2017;208:1110–15 doi:10.2214/AJR.16.16486 pmid:28245145
    CrossRefPubMed
  21. 21.↵
    1. Katonis  P, 
    2. Alpantaki  K, 
    3. Michail  K, et al
    . Spinal chondrosarcoma: a review. Sarcoma 2011;2011:378957 doi:10.1155/2011/378957 pmid:21437176
    CrossRefPubMed
  22. 22.
    1. Fromm  J, 
    2. Klein  A, 
    3. Baur-Melnyk  A, et al
    . Survival and prognostic factors in conventional central chondrosarcoma. BMC Cancer 2018;18:849 doi:10.1186/s12885-018-4741-7 pmid:30143018
    CrossRefPubMed
  23. 23.↵
    1. Bergh  P, 
    2. Kindblom  LG, 
    3. Gunterberg  B, et al
    . Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 2000;88:2122–34 doi:10.1002/(SICI)1097-0142(20000501)88:9<2122::AID-CNCR19>3.0.CO;2-1 pmid:10813725
    CrossRefPubMedWeb of Science
  24. 24.↵
    1. Santos  P, 
    2. Peck  KK, 
    3. Arevalo-Perez  J, et al
    . T1-weighted dynamic contrast-enhanced MR perfusion imaging characterizes tumor response to radiation therapy in chordoma. AJNR Am J Neuroradiol 2017;38:2210–16 doi:10.3174/ajnr.A5383 pmid:28912284
    Abstract/FREE Full Text
  25. 25.↵
    1. De Coninck  T, 
    2. Jans  L, 
    3. Sys  G, et al
    . Dynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma. Eur Radiol 2013;23:3140–52 doi:10.1007/s00330-013-2913-z pmid:23771600
    CrossRefPubMed
  26. 26.↵
    1. Morales  KA, 
    2. Arevalo-Perez  J, 
    3. Peck  KK, et al
    . Differentiating atypical hemangiomas and metastatic vertebral lesions: the role of T1-weighted dynamic contrast-enhanced MRI. AJNR Am J Neuroradiol 2018;39:968–73 doi:10.3174/ajnr.A5630 pmid:29650780
    Abstract/FREE Full Text
  27. 27.↵
    1. Saha  A, 
    2. Peck  KK, 
    3. Lis  E, et al
    . Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications. Spine (Phila Pa 1976) 2014;39:E1433–40 doi:10.1097/BRS.0000000000000570 pmid:25188594
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging
  
    	
Y. Ota, E. Liao, A.A. Capizzano, A. Baba, R. Kurokawa, M. Kurokawa, A. Srinivasan

  
    	
American Journal of Neuroradiology Sep 2022, 43 (9) 1325-1332; DOI: 10.3174/ajnr.A7607 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement